Effective dates for CE credit: 11/19/2025 – 11/30/2027
Total credits: 8.25 CE/CME (all modules)
Target Audience:  Nurses, Dietitians, Pharmacists, PAs, Physicians. NOTE: Nurse Practitioners seeking AANP credit must instead register for the program with AANP

Program Overview

The Clinical Advantage Bootcamp equips healthcare professionals with the knowledge and confidence to lead in every aspect of type 1 diabetes care—from early recognition to advanced treatment and technology use. Through practical, evidence-based learning, participants will strengthen clinical decision-making and whole-person management skills. This program empowers leaners to transform care and outcomes for individuals living with T1D.

• The certificate program is made up of seven online modules -- you can take as many of them as you wish, for CE/CME credit. (Total available credits: 8.25 CE/CME)
• If you complete all seven modules. you will earn the program certificate of completion.
• MODULES (see full descriptions below)
  1. The State of the Science in Type 1 Diabetes (1.25 CE/CME)
  2. Putting Type 1 Diabetes in Clinical Context (1.25 CE/CME)
  3. Examining the Evidence (1.25 CE/CME)
  4. Supporting Type 1 Diabetes Care with Technology (1.0 CE/CME)
  5. Putting Knowledge Into Practice in Type 1 Diabetes (1.0 CE/CME)
  6. Addressing Psychosocial Challenges and Social Determinants of Health (1.0 CE/CME)
  7. Managing Type 1 Diabetes in Primary Care (1.5 CE/CME)
  
  

Important Note for Nurse Practitioners: Nurse Practitioners seeking AANP credit must register for this program with AANP. Others should register through this web page.

Program Objectives

• Describe the prevalence, pathophysiology, and patient burden of type 1 diabetes (T1D), including common comorbidities and clinical complications.
• Review current standard of care best practices for T1D screening, as a means of achieving early recognition and diagnosis, and disease staging, as a means of informing treatment.
• Evaluate the established and evolving evidence for novel T1D therapeutics, with a focus on recent FDA approvals and the emerging era of disease modification.
• Examine the expanding impact of technology on T1D management, emphasizing the prominence of continuous glucose monitoring (CGM), automated insulin delivery (AID) systems, and “smart” devices across the totality of the T1D paradigm.
• Recognize the role of primary care clinicians as sentinels in the T1D management landscape, leading the charge in disease recognition, staging, and the establishment of multidisciplinary referral pathways for treatment linkage and collaborative longitudinal care.
• Discuss the harmful effects of social determinants of health (SDOH) on the overarching quality of patient-centric T1D care.
• Identify the vast psychosocial burden of T1D, highlighting best practices for mitigating this burden, managing diabetes distress, and provisioning patient support for mental and emotional health.

Module Descriptions

MODULE 1: The State of the Science in Type 1 Diabetes: Best Practice Screening, Staging, and Treatment
Kathryn Evans-Kreider, DNP, APRN, FAANP, FNP-BC
Lucia Novak MSN, ANP-BC, BC-ADM

This module is designed to provide an in-depth overview of type 1 diabetes (T1D) for primary care clinicians. It explores current epidemiology, diagnostic challenges, and the latest evidence-based practices for early screening and disease staging. The presentation also highlights emerging disease-modifying therapies, advances in diabetes technology, and the critical role of nurse practitioners in early detection, treatment coordination, and patient-centered care. (1.25 CE/CME)

Objectives:

• Describe the prevalence, pathophysiology, and patient burden of type 1 diabetes (T1D), including common comorbidities and clinical complications.
• Review the current standard of care best practices for T1D screening, as a means of achieving early recognition and diagnosis, disease staging, and informing treatment.
• Recognize the role of primary care clinicians as sentinels in the T1D management landscape, leading the charge in disease recognition, staging, and the establishment of multidisciplinary referral pathways for treatment linkage and collaborative care.

MODULE 2: Putting Type 1 Diabetes in Clinical Context: An Overview of Comorbidities and Complications
Angela Thompson DNP, FNP-C, BC-ADM, CDCES, FAANP
Nykkia Sellers DNP, FNP, BC-ADM, CDCES

This module is a comprehensive exploration of the multisystem impact of type 1 diabetes (T1D). It examines acute and chronic complications—such as diabetic ketoacidosis (DKA), retinopathy, nephropathy, neuropathy, and cardiovascular disease—while emphasizing early recognition, patient education, and risk mitigation strategies. The module also highlights the importance of whole-person, primary care–driven management that integrates screening for comorbidities, psychosocial assessment, and collaboration across specialties to optimize outcomes for individuals living with T1D. (1.25 CE/CME)

Objectives:

• Describe the prevalence, pathophysiology, and patient burden of type 1 diabetes (T1DM), including common comorbidities and clinical complications.
• Recognize the role of primary care clinicians as sentinels in the T1DM management landscape, leading the charge in disease recognition and staging.
• Establish multidisciplinary referral pathways for treatment linkage and collaborative care. 

MODULE 3: Examining the Evidence: Established & Emerging Type 1 Diabetes Therapeutic Strategies
Nykkia Sellers DNP, FNP, BC-ADM, CDCES
Lucia Novak MSN, ANP-BC, BC-ADM

This module focuses on evidence-based and novel treatment approaches for type 1 diabetes (T1D). It provides a comprehensive review of insulin therapy—covering dosing principles, pharmacodynamics, delivery methods, and injection best practices—while emphasizing individualized glycemic goals. The presentation also explores the advent of disease-modifying and cellular therapies such as teplizumab and donislecel, illustrating how these FDA-approved innovations represent a new era in T1D management aimed at delaying disease progression and restoring beta-cell function. (1.25 CE/CME)

Objectives:

• Evaluate the established and evolving evidence for novel T1D therapeutics.
• Discuss recent FDA approvals for the treatment of T1D.
• Appraise disease modification capability of emerging therapeutics.

MODULE 4: Supporting Type 1 Diabetes Care with Technology: A Hands-On Guide
Dana Roseman MPH, CDCES, RDN, LDN

This module explores the expanding role of digital and device-based innovations in optimizing type 1 diabetes (T1D) management. It provides practical guidance on integrating continuous glucose monitoring (CGM), smart insulin pens, and automated insulin delivery (AID) systems into clinical practice to improve glycemic control, reduce disease burden, and enhance patient engagement. The presentation also addresses barriers to technology access and equity, emphasizing how primary care clinicians can champion the use of diabetes technologies through education, advocacy, and individualized, patient-centered implementation. (1.0 CE/CME)

Objective:

• Examine the expanding impact of hands-on use of technology on T1D management, emphasizing the prominence of continuous glucose monitoring (CGM), automated insulin delivery (AID) systems, and “smart” devices across the totality of the T1D paradigm. 

MODULE 5: Putting Knowledge Into Practice in Type 1 Diabetes: An Interactive Case Module
Angela Thompson DNP, FNP-C, BC-ADM, CDCES, FAANP

This module immerses learners in real-world case scenarios across the lifespan to strengthen skills in early recognition, staging, and management of type 1 diabetes (T1D). Participants will explore current standards of care, emerging therapeutics, and the expanding role of technology and multidisciplinary collaboration in optimizing patient outcomes. (1.0 CE/CME)

Objectives:

• Review the current standard of care best practices for T1D screening, as a means of achieving early recognition and diagnosis, disease staging, and informing treatment.
• Examine the expanding impact of technology on T1D management, emphasizing the prominence of continuous glucose monitoring (CGM), automated insulin delivery (AID) systems, and “smart” devices across the totality of the T1D paradigm.
• Recognize the role of primary care clinicians as sentinels in the T1D management landscape, leading the charge in disease recognition, staging, and the establishment of multidisciplinary referral pathways for treatment linkage and collaborative care.

MODULE 6: Addressing Psychosocial Challenges and Social Determinants of Health (SDOH) to Better Support Patients Who are Living with Type 1 Diabetes
Kathryn Evans-Kreider, DNP, APRN, FAANP, FNP-BC
Korey Hood, PhD

This module explores the human side of type 1 diabetes, highlighting the emotional, psychological, and social challenges faced by patients and families. Participants will learn practical, person-centered strategies to identify diabetes distress, address social determinants of health, and foster empathetic, equitable care that supports long-term well-being. (1.0 CE/CME)

Objectives:

• Discuss the harmful effects of social determinants of health (SDOH) on the overarching quality of patient-centric T1D care.
• Identify the vast psychosocial burden of T1D, highlighting best practices for mitigating this burden, managing diabetes distress, and provisioning patient support for mental and emotional health.

MODULE 7: Managing Type 1 Diabetes in Primary Care: The Paramount Placement of the Nurse Practitioner
Kathryn Evans-Kreider, DNP, APRN, FAANP, FNP-BC
Angela Thompson DNP, FNP-C, BC-ADM, CDCES, FAANP

This module empowers nurse practitioners to lead the early recognition, diagnosis, and management of type 1 diabetes across care settings. Through a case-based approach, learners will explore evidence-based strategies for differential diagnosis, insulin and technology management, and addressing psychosocial and health equity factors that shape T1D outcomes. (1.5 CE/CME)

Objectives:

• Recognize the role of primary care clinicians as sentinels in the T1D management landscape.
• Identify T1D in patients at risk for disease.
• Evaluate laboratory data and clinical signs to determine T1D stage.
• Devise multidisciplinary referral pathways for treatment linkage and collaborative care.
• Individualize medication management plan based on A1C and TIR goals, risk of DKA and diabetes co-morbid conditions.

Kathryn Evans-Kreider, DNP, APRN, FAANP, FNP-BC
Dr. Kathryn Kreider is a professor of nursing at Duke University and the director of the endocrinology specialty program for NPs. She has an active clinical practice in endocrinology. She is a nationally recognized speaker in topics of diabetes and endocrinology and was appointed to the American Diabetes Association Professional Practice Committee which writes the Standards of Medical Care in Diabetes.

Korey Hood, PhD
Korey Hood, PhD is personally and professionally committed to improving the lives of people with diabetes. As Professor and Staff Psychologist at Stanford University School of Medicine, Dr. Hood runs a behavioral science laboratory aimed at optimizing health and quality of life outcomes. A recipient of federal and foundation grants and author of over 200 scientific articles, Dr. Hood works to put behavioral science at the forefront of person-centered diabetes care. Dr. Hood has type 1 diabetes himself and works across advocacy and service settings to promote awareness of diabetes treatments, the psychological impact, and emerging technologies. Dr. Hood is a compassionate behavioral scientist with a keen understanding of the intersection between diabetes and behavioral health.

Lucia Novak, MSN, ANP-BC, BC-ADM
Ms. Novak, President and Founder of Diabesity, LLC, is Board Certified as both an Adult Health Nurse Practitioner and an Advanced Diabetes Manager with over 30 years of clinical expertise. She is a Consultant, Advisor, National Speaker, Author, Educator, and passionate Advocate in the field of diabetes and obesity.

Dana Roseman, MPH, CDCES, RDN, LDN
Dana is the Director of Technology and Applied Research at Integrated Diabetes Services, a leader in remote diabetes consulting. She is a Certified Diabetes Care & Education Specialist and Registered Dietitian, and holds certifications in insulin pump therapy and obesity interventions for adults. After being diagnosed with Type 1 Diabetes and working closely with her diabetes educator, Dana was inspired to help others with their diabetes management.  For almost 20 years, Dana has focused on helping improve patients’ lives through diabetes technology and applied research. She has been involved in over 20 cutting-edge clinical trials related to advanced diabetes and obesity interventions. Dana is also a pioneer in the area of closed loop “artificial pancreas” systems and uses a hybrid closed-loop system personally. Dana serves as the Research Information Liaison for the Dallas chapter of Juvenile Diabetes and Research Foundation (JDRF) and serves on the JDRF National Speakers Bureau. 

Nykkia Sellers, DNP, FNP, BC-ADM, CDCES
Dr. Nykkia Sellers, NP is a board-certified family nurse practitioner (NP) with over 20 years of experience. She specializes in management of diabetes and other chronic diseases in adults. NP Sellers is a certified diabetes care and education specialist and has a board certification in Advanced Diabetes Management. Currently, Dr. Sellers serves on the Advisory Group for the Women’s Interprofessional Network of the American Diabetes Association. She also serves on the Credential Committee for the Certification Board for Diabetes Care & Education. She has been invited to speak nationally to discuss diabetes management and awareness. Dr. Sellers has published articles and developed diabetes courses for healthcare providers and professionals, and she is the recent recipient of the American Association of Nurse Practitioners® 2025 State Award for Arkansas.

Angela Thompson, DNP, FNP-C, BC-ADM, CDCES, FAANP
Dr. Angela Thompson is the recording secretary for the American Association of Nurse Practitioners® (AANP). Dr. Thompson previously served as the Region 5 Director. She has been a nurse practitioner (NP) for 15 years. Thompson currently works as an NP in an outpatient hospital endocrinology clinic with inpatient privileges. She is a visionary leader, change agent and role model for NPs in Indiana. She is a former AANP Indiana State Representative. She is actively involved in health care policy and advocacy and strives to advance the NP profession by mentoring the next generation of NP leaders. 

Important Note for Nurse Practitioners: Nurse Practitioners seeking AANP credit must register for this program with AANP. 

Nurses, Dietitians, Pharmacists, PAs, Physicians: Please see below for accreditation details regarding CE/CME offered with this program (registration is through this web page).

Accreditation Details

In support of improving patient care, this activity has been planned by the American Association of Nurse Practitioners and the Association of Diabetes Care & Education Specialists. The Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Available Modules and Credit Information

Module 1: The State of the Science in Type 1 Diabetes – Best Practice Screening, Staging, and Treatment
1.25 CME credits/contact hours
UAN: JA4008258-9999-25-324-H01-P

Module 2: Putting Type 1 Diabetes in Clinical Context – An Overview of Comorbidities and Complications
1.25 CME credits/contact hours
UAN: JA4008258-9999-25-325-H01-P

Module 3: Examining Evidence – Established & Emerging Type 1 Diabetes Therapeutic Strategies
1.25 CME credits/contact hours
UAN: JA4008258-9999-25-326-H01-P

Module 4: Supporting Type 1 Diabetes Care with Technology – A Hands-On Guide
1.0 CME credits/contact hours
UAN: JA4008258-9999-25-327-H01-P

Module 5: Putting Knowledge into Practice in Type 1 Diabetes – An Interactive Case Module
1.0 CME credits/contact hours
UAN: JA4008258-9999-25-328-H01-P

Module 6: Addressing Psychosocial Challenges and Social Determinants of Health (SDOH) to Better Support Patients Living with Type 1 Diabetes
1.0 CME credits/contact hours
UAN: JA4008258-9999-25-329-H01-P

Module 7: Managing Type 1 Diabetes in Primary Care – The Paramount Placement of the Nurse Practitioner
1.5 CME credits/contact hours
UAN: JA4008258-9999-25-330-H01-P

	Accreditation Council for Pharmacy Education (ACPE) The Universal Activity Number varies per module. See the specific UAN number for each module listed above. This application-based activity has been approved for 8.25 contact hour(s). This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.
	American Medical Association (AMA) Association of Diabetes Care & Education Specialists designates this enduring material for a maximum of 8.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
	American Nurses Credentialing Center (ANCC) Association of Diabetes Care & Education Specialists designates this activity for a maximum of 8.25 ANCC contact hour(s). This activity discusses 1.75 contact hour(s) of pharmacotherapeutic content.  The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 8.25 contact hour(s).
	American Academy of PAs (AAPA) The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.25 AAPA Category 1 CME credit(s). Approval is valid until 11/30/27. PAs should only claim credit commensurate with the extent of their participation.

Commission on Dietetic Registration (CDR) CDR Credentialed Practitioners will receive 8.25 Continuing Professional Education unit(s) (CPEU) for completion of this activity.  Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One hour/60 minutes = 1 CPEU.) RDs and DTRs are to select activity type 102 in their Activity Logs. Performance Indicator election is at the learner’s discretion.

Certified Diabetes Care and Education Specialists

To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.

Other Health Professionals

It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.

Successful Completion

Upon completing the coursework, post-test, and course evaluation, you’ll be able to access your statement of credit, which reflects the CE credit you earned. Please print and retain a copy for your records. You may return to this page later to reprint it if necessary.

Pharmacists must provide their date of birth (MMDD) and NABP ePID to receive credit. Pharmacist learners who fail to provide this information will not receive credit for this activity.

Disclaimer

The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Financial Support: This collaboration between danatech, the Association of Diabetes Care & Education Specialists, and the American Association of Nurse Practitioners is made possible through unrestricted educational grants from Abbott and Medtronic.

We also gratefully acknowledge the Helmsley Charitable Trust for its independent grant support.

In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.

Joint Accreditation/ACCME requires ADCES to identify and mitigate all relevant financial relationships with ineligible companies to ensure educational content is balanced, evidence-based, and free from bias. Disclosure information is provided to help learners recognize any relevant financial relationships and make their own informed judgments about the content. If you perceive any bias during the activity, please report it through the evaluation form.

Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:

Planners:

• Cammie Hauser MSN, FNP-BC: No Financial relationships to report 
• Patty Scalzo MSN, ANP-BC, CDCES: No financial relationships to report 

Presenters:

• Kathryn Evans-Kreider DNP, APRN, FAANP, FNP-BC: Madrigal Pharmaceuticals (Advisor/consultant)
• Korey Hood PhD: No relevant financial relationships to report 
• Nykkia Sellers DNP, FNP, BC-ADM, CDCES: No financial relationships to report
• Lucia Novak MSN, ANP-BC, BC-ADM: Abbott, Ascensia, Nestle, Novo Nordisk, Sanofi (Speaker, Consultant, and Advisory Boards)
• Dana Roseman MPH, CDCES, RDN, LDN: No financial relationships to report
• Angela Thompson DNP, FNP-C, BC-ADM, CDCES, FAANP: Tandem Diabetes (Travel expense funding for a different project)

All relevant financial relationships have been mitigated.

The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Pricing

Members: $0
Non-Members: $0

Access Period

Expiration date: 11/30/2027